MASH awareness survey completed: no treatment, just insights
NCT ID NCT07201831
First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 35 times
Summary
This study used online questionnaires to understand how well healthcare providers and people with or at risk for MASH (a liver disease) understand the links between MASH and heart, kidney, and metabolic conditions. About 1,330 participants completed the 25-minute survey. The goal was to gather information for future research, not to test any treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novo Nordisk Investigational Site
Plainsboro, New Jersey, 08536, United States
-
Novo Nordisk Investigational Site
Mississauga, Canada
-
Novo Nordisk Investigational Site
Puteaux, France
-
Novo Nordisk Investigational Site
Mainz, Germany
-
Novo Nordisk Investigational Site
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.